PM
Priyanka Mishra
About Priyanka Mishra
Data last updated:
Priyanka Mishra is a Director at Sparse Pharma Private Limited (since 2020) and Designated Partner at Spradda Pharmaceutical Llp (since 2024). The companies operate in Chemicals. The largest current company by reported revenue is Sparse Pharma Private Limited at ₹7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Nov 2020 | 2020 | ₹7 Lakh (FY 2025) | Active | |
| Designated Partner | 12 Jun 2024 | 2024 | Active |
Board colleagues of Priyanka Mishra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Reena Devi | 08745166 | Sparse Pharma Private Limited | Director |
| Saurav Dwivedi | 10665448 | Spradda Pharmaceutical Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priyanka Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priyanka Mishra
Priyanka Mishra currently holds 2 directorships: Sparse Pharma Private Limited (Director, since 19 Nov 2020, revenue ₹7 Lakh (FY 2025)); Spradda Pharmaceutical Llp (Designated Partner, since 12 Jun 2024).
Priyanka Mishra was first appointed on 19 Nov 2020 as Director at Sparse Pharma Private Limited. The most recent appointment on record is 12 Jun 2024 at Spradda Pharmaceutical Llp.
The current boards of Priyanka Mishra's companies include Reena Devi (Sparse Pharma Private Limited), Saurav Dwivedi (Spradda Pharmaceutical Llp).